26 results on '"Sidoni T"'
Search Results
2. Identification and Characterization of BRCA1 and BRCA2 Founder Mutations
3. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models
4. From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters
5. Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama
6. First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience
7. Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors
8. Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel
9. 1780P - Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors
10. Abstract P2-09-14: Surveillance program for women carrying BRCA1/BRCA2 genetic predisposition
11. The impact of searching for BRCA1/2 large genomic rearrangement on BRCAPRO carrier prediction
12. Different rate of BRCA1/BRCA2 predisposing mutations according to family history and clinical criteria of breast/ovarian cancer risk
13. Identification of families selected for breast cancer predisposition risk and showing low rate of BRCA1/BRCA2 mutations (< 10%)
14. Identification and Characterization of BRCA1 and BRCA2 Founder Mutations
15. Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
16. Bone recurrence in early breast cancer patients: The paradox of aromatase inhibitors induced bone resorption.
17. Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study.
18. Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes.
19. The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A 'hypothesis-generator' study from clinical practice.
20. Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.
21. Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study.
22. Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
23. Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer.
24. Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.
25. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
26. Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.